ClinicalTrials.Veeva

Menu

Herbal Patch for Overactive Bladder

E

En Chu Kong Hospital

Status and phase

Completed
Phase 3
Phase 2

Conditions

Overactive Bladder Syndrome

Treatments

Drug: herbal patch
Drug: placebo patch

Study type

Interventional

Funder types

Other

Identifiers

NCT03532789
ECKIRB1051203

Details and patient eligibility

About

Overactive bladder is a clinical syndrome characterized by frequency, with or without urge incontinence, urgency, and nocturia, which affect patients' sleeping quality and rehabilitation program progressing. Current treatments include behavioral therapy (eg, life style adjustment, bladder training, pelvic floor muscle therapy) and medication. Antimuscarinic agents is the most common medications prescribed for OAB, but patients often have side effects like dry mouth and constipation. And there were plenty of herbal medicine which are beneficial to urine frequency and voiding dysfunction in ancient Chinese medicine books and records. In human trial, 62 Subjects diagnosed as overactive bladder will be enrolled and treated with Cinnamon patch. After treatment we will estimate the efficacy and record adverse events to conduct statistically analysis.

Full description

Overactive bladder is a clinical syndrome characterized by frequency, with or without urge incontinence, urgency, and nocturia, which affect patients' sleeping quality and rehabilitation program progressing. Current treatments include behavioral therapy (eg, life style adjustment, bladder training, pelvic floor muscle therapy) and medication. Antimuscarinic agents is the most common medications prescribed for OAB, but patients often have side effects like dry mouth and constipation. And there were plenty of herbal medicine which are beneficial to urine frequency and voiding dysfunction in ancient Chinese medicine books and records. In human trial, 62 Subjects diagnosed as overactive bladder will be enrolled and treated with Cinnamon patch. After treatment we will estimate the efficacy and record adverse events to conduct statistically analysis.

The 1st year project: (1) Expect to enroll 62 clinical subjects of OAB. (2) Evaluate subjects 'symptom and proceed patch treatment. (3) Record treatment responses including adverse effect. (4) Conduct statistically analysis.

The 2nd year project: (1) Completing enrollment of 62 clinical subjects of OAB. (2) Finish evaluation and treatment of all subjects. (3) Statistically analysis all collecting data (4) Discuss and analyze the outcome.

Enrollment

66 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • urgency score of OABSS ≥ 2 or total score of OABSS ≥ 3

Exclusion criteria

  • suffering from acute urinary tract infection
  • recurrent urinary tract infection ≥ 5 times in the last year
  • Hematuria or bladder stone disease
  • using foley catheter
  • Pregnant or breastfeeding women
  • Spinal cord injury patients
  • Mental illness or substance abuse
  • taking medicine for the treatment of overactive bladder within one month

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

66 participants in 2 patient groups, including a placebo group

herbal patch group
Experimental group
Description:
using herbal patch as an intervention
Treatment:
Drug: herbal patch
placebo patch group
Placebo Comparator group
Description:
using placebo patch as an intervention
Treatment:
Drug: placebo patch

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems